Article
Sensitivity to BUB1B Inhibition Defines an Alternative Classification of Glioblastoma
30 Aug 2017
Abstract excerpt
Abstract Glioblastoma multiforme (GBM) remains a mainly incurable disease in desperate need of more effective treatments. In this study, we develop evidence that the mitotic spindle checkpoint molecule BUB1B may offer a predictive marker for aggressiveness and effective drug response. A subset of GBM tumor isolates requires BUB1B to suppress lethal kinetochore–microtubule attachment defects. Using gene expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
